600721 百花醫藥
按盤價 
6.950 +0.040 (+0.579%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.312 | 1.889 | -5.157 | 9.200 | -40.630 |
| 總資產報酬率 ROA (%) | 2.188 | 1.257 | -3.505 | 6.114 | -28.224 |
| 投入資產回報率 ROIC (%) | 2.682 | 1.551 | -4.287 | 7.646 | -35.761 | 邊際利潤分析 |
| 銷售毛利率 (%) | 46.465 | 49.037 | 39.918 | 40.039 | -161.954 |
| 營業利潤率 (%) | 9.339 | 4.862 | -8.786 | 22.584 | -438.647 |
| 息稅前利潤/營業總收入 (%) | 8.974 | 4.229 | -9.258 | 22.061 | -353.334 |
| 淨利潤/營業總收入 (%) | 8.242 | 3.513 | -9.928 | 21.281 | -378.283 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 201.896 | 413.100 | -82.173 | 54.055 | 73.178 |
| 價值變動淨收益/利潤總額(%) | 9.464 | 11.860 | -0.034 | 0.707 | -2.330 |
| 營業外收支淨額/利潤總額(%) | -0.330 | -8.946 | 4.282 | -2.197 | -17.458 | 償債能力分析 |
| 流動比率 (X) | 1.815 | 1.831 | 1.749 | 1.844 | 1.429 |
| 速動比率 (X) | 1.458 | 1.426 | 1.232 | 1.079 | 0.818 |
| 資產負債率 (%) | 34.354 | 33.464 | 33.410 | 30.139 | 35.962 |
| 帶息債務/全部投入資本 (%) | 14.726 | 12.728 | 11.984 | 10.955 | 12.088 |
| 股東權益/帶息債務 (%) | 544.472 | 642.967 | 687.595 | 765.453 | 680.754 |
| 股東權益/負債合計 (%) | 191.091 | 198.825 | 199.308 | 230.123 | 176.670 |
| 利息保障倍數 (X) | -26.876 | -18.028 | 117.429 | -581.341 | -17.565 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 22.132 | 17.451 | 19.092 | 25.494 | 547.610 |
| 存貨周轉天數 (天) | 213.612 | 262.317 | 294.099 | 408.022 | 345.723 |
| 備註： | 即時報價更新時間為 19/11/2024 12:46 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
